dr. pegram on a phase ii trial of mgah22 in breast cancer
Published 10 years ago • 277 plays • Length 1:45Download video MP4
Download video MP3
Similar videos
-
1:31
dr. pegram on margetuximab plus chemo in her2 breast cancer
-
2:30
dr. pegram on neoadjuvant treatments for her2-postive breast cancer
-
1:05
dr. pegram on pertuzumab plus trastuzumab and chemotherapy in breast cancer
-
1:19
dr. pegram discusses the use of neratinib in her2 breast cancer
-
1:53
dr. pegram on pertuzumab combination for her2-positive breast cancer
-
1:22
dr. pegram on challenges facing the treatment of her2-positive breast cancer
-
2:14
dr. pegram on sequencing therapies in her2-positive breast cancer
-
1:12
dr. pegram on challenges in neoadjuvant treatment for her2-positive breast cancer
-
1:13
dr. pegram discusses adjuvant pertuzumab in her2 breast cancer
-
1:06
dr. mark pegram on combining trastuzumab and pertuzumab
-
1:41
dr. pegram on the development of trastuzumab biosimilars
-
2:03
dr. pegram on promising novel agents in her2 metastatic breast cancer
-
1:52
dr. mark pegram discusses earlier treatment with t-dm1
-
2:12
dr. pegram on pertuzumab and trastuzumab in breast cancer
-
2:35
dr. rugo on the phase iii sophia trial in her2 breast cancer
-
1:51
dr. pegram on future impact of biosimilars in oncology
-
2:02
dr. pegram on early treatment with t-dm1
-
1:24
dr. catenacci on study of margetuximab plus pembrolizumab in gastric:gej cancer
-
4:05
sophia trial in r/r her2 mbc